Literature DB >> 26760594

Evaluation of the Solitary Pulmonary Nodule.

George E Kikano1, Andre Fabien2, Robert Schilz2.   

Abstract

A solitary pulmonary nodule is a common radiologic finding that is often discovered incidentally and may require significant workup to establish a definitive diagnosis. A solitary pulmonary nodule is a well-circumscribed round lesion measuring up to 3 cm in diameter and surrounded by aerated lung. Once a nodule is discovered, clinical and radiologic features and quantitative models can be used to determine the likelihood of malignancy. Evaluation is guided by nodule size and assessment of probability of malignancy. Surgical resection or nonsurgical biopsy should be performed in patients with solid or subsolid solitary pulmonary nodules that show clear growth on serial imaging. Solid solitary pulmonary nodules that have been stable for at least two years typically do not need further evaluation. The workup for patients with solid solitary pulmonary nodules measuring 8 mm or greater in diameter, nodules measuring less than 8 mm in diameter, and subsolid nodules should be guided by the probability of malignancy, imaging results, and the risks and benefits of different management strategies. Management should be individualized according to patient values and preferences. Medicare now covers lung cancer screening with low-dose computed tomography for high-risk patients 55 to 77 years of age at institutions that can provide a comprehensive approach to the management of solitary pulmonary nodules.

Entities:  

Mesh:

Year:  2015        PMID: 26760594

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  8 in total

1.  Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.

Authors:  Margarita Kirienko; Luca Cozzi; Alexia Rossi; Emanuele Voulaz; Lidija Antunovic; Antonella Fogliata; Arturo Chiti; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-06       Impact factor: 9.236

Review 2.  Recent advances in the management of pulmonary tuberculoma with focus on the use of tubeless video-assisted thoracoscopic surgery.

Authors:  Zhaohua Xia; Kun Qiao; Jianxing He
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  Differential diagnosis of solitary pulmonary nodules with dual-source spiral computed tomography.

Authors:  Zhitao Shi; Yanhui Wang; Xueqi He
Journal:  Exp Ther Med       Date:  2016-07-15       Impact factor: 2.447

4.  Computed tomography-guided percutaneous transthoracic needle biopsy for solitary pulmonary nodules in diameter less than 20 mm.

Authors:  Chunhua Xu; Qi Yuan; Chuanzhen Chi; Qian Zhang; Yuchao Wang; Wei Wang; Like Yu; Ping Zhan; Yong Lin
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  The value of the air bronchogram sign on CT image in the identification of different solitary pulmonary consolidation lesions.

Authors:  Huifang Qu; Wenchao Zhang; Jisheng Yang; Shouqin Jia; Guangbin Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

6.  Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort Study.

Authors:  Che-Liang Chung; Wei-Chang Huang; Hung-Ling Huang; Chun-Shih Chin; Meng-Hsuan Cheng; Meng-Rui Lee; Sheng-Hao Lin; Jann-Yuan Wang; Ching-Hsiung Lin; Inn-Wen Chong; Jin-Yuan Shih; Chong-Jen Yu
Journal:  Open Forum Infect Dis       Date:  2021-11-09       Impact factor: 3.835

7.  A rare etiology of pulmonary nodules.

Authors:  Arashdeep Rupal; Harpreet Singh; Chinmay Jani; Omar Al Omari; Dipesh Patel; John Perry; Carey C Thomson
Journal:  Respir Med Case Rep       Date:  2021-09-22

8.  Prediction of malignancy for solitary pulmonary nodules based on imaging, clinical characteristics and tumor marker levels.

Authors:  Hongjun Hou; Shui Yu; Zushan Xu; Hongsheng Zhang; Jie Liu; Wenjun Zhang
Journal:  Eur J Cancer Prev       Date:  2021-09-01       Impact factor: 2.164

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.